Jason Wild, a Director and 10% Holder, acquired 197,900 Common Shares on a direct ownership basis at prices ranging from $3.490 to $3.530 between November 22nd and 25th, 2019. This represents a $694,637 investment into the company's shares and an account share holdings change of greater than 100%.
TerrAscend is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.
TerrAscend Corp is a Canada-based company engaged in providing products, brands, and services to the cannabinoid market. The Company, through its subsidiary TerrAscend Canada Inc., is a producer of medical and adult use cannabis. It also operates through various businesses, including The Apothecarium, a cannabis dispensary with retail locations in California and Nevada; Arise Bioscience Inc., a manufacturer and distributor of hemp-derived products; Ascendant Laboratories Inc., a biotechnology and licensing company focused on cannabinoid expressing plants; Solace RX Inc., a Drug Preparation Premises (DPP) focused on the development of formulations and delivery forms; and Valhalla Confections, a manufacturer of premium cannabis-infused edibles. TerrAscend Corp. (TER) has below median officer and director direct ownership compared to its small-cap peers in the market, based on our estimate using SEDI data. According to regulatory filings yesterday, one insider has invested a total amount of $694,637.
No Comments